Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial
Titel:
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial
Auteur:
van Linschoten, Reinier C A Jansen, Fenna M Pauwels, Renske W M Smits, Lisa J T Atsma, Femke Kievit, Wietske de Jong, Dirk J de Vries, Annemarie C Boekema, Paul J West, Rachel L Bodelier, Alexander G L Gisbertz, Ingrid A M Wolfhagen, Frank H J Römkens, Tessa E H Lutgens, Maurice W M D van Bodegraven, Adriaan A Oldenburg, Bas Pierik, Marieke J Russel, Maurice G V M de Boer, Nanne K Mallant-Hent, Rosalie C ter Borg, Pieter C J van der Meulen-de Jong, Andrea E Jansen, Jeroen M Jansen, Sita V Tan, Adrianus C I T L van der Woude, C Janneke Hoentjen, Frank